MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Prostate
Kairos Pharma, LTD (KAPA)
Organization & Developments: Kairos Pharma
Parents
Kairos Pharma, LTD (KAPA)
Children
*Kairos Pharma is a clinical-stage biopharmaceutical company focused on cancer immunotherapy and drug resistance.
*The company develops peptide and small molecule cancer immunotherapeutic drug candidates.
2024: Kairos Pharma Readies Nano-IPO For Cancer Treatment Pipeline
2024: Kairos Pharma: Potential To Remove Resistance With Established Drugs
2025: Breakthrough Prostate Cancer Drug ENV-105 Achieves Critical Safety Milestone in Phase 2 Trial
Jumps
Finance & Acquisitions: Kairos Pharma
Key People: Kairos Pharma